Since Bcl-2 plays a role in autophagy, we further analyzed the TCGA database of prostate cancer patients and found the highest percentage of high-grade tumors in the cohort with low KLF5/high Bcl-2 levels. This evidence concerns the gene BCL2 and prostate carcinoma.